{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:44:13Z","timestamp":1785764653428,"version":"3.56.0"},"reference-count":80,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Continuous glucose monitoring (CGM) is central to diabetes care, but explaining CGM patterns consistently and empathetically remains time-intensive in clinical practice. Large language model (LLM)\u2013based systems may support patient-facing interpretation of CGM data, but evidence remains limited for retrieval-grounded tools evaluated against clinician-authored responses in counseling scenarios. The system was intended for CGM interpretation and communication support rather than autonomous therapeutic decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether a retrieval-grounded LLM-based conversational agent (CA) could support patient understanding of CGM data and preparation for diabetes consultations by generating responses to questions arising during CGM-informed diabetes counseling, with quality comparable to clinician-authored responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a scaffolded LLM-based CA for CGM interpretation and diabetes counseling support. The system was designed to provide plain-language explanations of CGM patterns and responses to diabetes management questions while avoiding directive or individualized medical advice, such as recommending medication initiation, dose adjustment, or regimen changes. Around 12 CGM-informed cases, each comprising a deidentified CGM trace, a synthetic patient vignette, and accompanying CGM visual materials, were constructed from using available clinical datasets. Between October 2025 and February 2026, 6 senior UK diabetes clinicians each reviewed 2 assigned cases and answered 24 questions (12 per case). In a source-masked multirater evaluation, each CA-generated and clinician-authored response was independently rated by 3 clinicians on 6 quality dimensions, including clinical accuracy, guideline adherence, actionability, personalization, communication clarity, and empathy. Safety flags and perceived source labels were also recorded. The primary analysis used linear mixed effects models with random intercepts for case and rater.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 288 unique responses (144 CA and 144 clinician responses) were evaluated, generating 864 ratings. CA-generated responses received higher quality scores than clinician-authored responses under controlled vignette-based conditions, with mean scores of 4.37 (SD 0.57) versus 3.58  and an estimated mean difference of 0.782 points on a 5-point scale (95% CI 0.692\u20100.872;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). This pattern was observed across all 6 categories of patient questions. The largest estimated differences were for empathy (mean difference 1.062, 95% CI 0.948\u20101.177) and actionability (0.992, 95% CI 0.877\u20101.106). Safety flag distributions were similar between CA and clinician responses, with major concerns rare in both groups (n=3, 0.7% each). Although CA responses were longer, additional analyses adjusting for word count did not indicate that response length explained the overall quality difference.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Scaffolded LLM-based systems may have value as adjunct tools for CGM review, patient education, and preconsultation preparation by supporting standardized explanatory tasks. However, these findings should be interpreted in light of the vignette-based design, restricted datasets, and a small clinician panel, and they do not establish suitability for autonomous therapeutic decision-making, medication adjustment, or unsupervised real-world use. Prospective validation in clinical workflows is needed before implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/98519","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:58:47Z","timestamp":1782838727000},"page":"e98519-e98519","source":"Crossref","is-referenced-by-count":0,"title":["Retrieval-Augmented Large Language Model Counseling for Continuous Glucose Monitoring in Diabetes: Source-Masked Multirater Comparative Evaluation"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1901-5191","authenticated-orcid":false,"given":"Zhijun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-8095","authenticated-orcid":false,"given":"Alvina","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-5488","authenticated-orcid":false,"given":"Emmanouil","family":"Korakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-7806","authenticated-orcid":false,"given":"Aristeidis","family":"Vagenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8011-777X","authenticated-orcid":false,"given":"Irshad","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-5734","authenticated-orcid":false,"given":"Christo","family":"Albor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-8124","authenticated-orcid":false,"given":"Hengrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-8091","authenticated-orcid":false,"given":"Justin","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-3128","authenticated-orcid":false,"given":"Kezhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"R1","unstructured":"Diabetes. National Health Service. 2025. URL: https:\/\/www.nhs.uk\/conditions\/diabetes\/ [Accessed 15-07-2026]"},{"key":"R2","unstructured":"Diabetes facts & figures. International Diabetes Federation. 2025. URL: https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/ [Accessed 15-07-2026]"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1620307","article-title":"Digital management of diabetes global research trends: a bibliometric study","volume":"12","author":"Zhu","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"R4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s44360-025-00021-w","article-title":"A community-codesigned LLM-powered chatbot for primary care: a randomized controlled trial","volume":"1","author":"Li","journal-title":"Nat Health"},{"issue":"8","key":"R5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s13300-023-01431-3","article-title":"Expanding the role of continuous glucose monitoring in modern diabetes care beyond type 1 disease","volume":"14","author":"Klupa","journal-title":"Diabetes Ther"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Bergenstal RM . Understanding continuous glucose monitoring data. In: Hirsch IB , editor. Role of Continuous Glucose Monitoring in Diabetes Treatment. American Diabetes Association; 2018:20-23. [doi: 10.2337\/db20181-20] [Medline: 34251769]","DOI":"10.2337\/db20181-7"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00626-5","article-title":"Enhancing self-management in type 1 diabetes with wearables and deep learning","volume":"5","author":"Zhu","journal-title":"NPJ Digit Med"},{"issue":"3","key":"R8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/26350106251326517","article-title":"Intermittent use of continuous glucose monitoring in type 2 diabetes is preferred: a qualitative study of patients\u2019 experiences","volume":"51","author":"Bendixen","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"Suppl 1","key":"R9","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023","volume":"46","author":"ElSayed","journal-title":"Diabetes Care"},{"issue":"10","key":"R10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3949\/ccjm.91a.23090","article-title":"Using continuous glucose monitoring data in daily clinical practice","volume":"91","author":"Martens","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"R11","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s11606-023-08222-3","article-title":"Rates and correlates of uptake of continuous glucose monitors among adults with type 2 diabetes in primary care and endocrinology settings","volume":"38","author":"Mayberry","journal-title":"J Gen Intern Med"},{"key":"R12","unstructured":"Dexcom clarity reports overview. Dexcom. URL: https:\/\/provider.dexcom.com\/education-research\/cgm-education-use\/product-information\/dexcom-clarity-reports-overview [Accessed 02-04-2026]"},{"key":"R13","unstructured":"Abbott. FreeStyle libre software reports tour. LibreView. 2024. URL: https:\/\/www.libreview.com\/files\/documents\/en-GB\/FSReportTour_2024-08-19.pdf [Accessed 02-04-2026]"},{"issue":"12","key":"R14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1753-0407.13454","article-title":"Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: a systematic review of qualitative studies","volume":"15","author":"Natale","journal-title":"J Diabetes"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0239-1","article-title":"Patients\u2019 and caregivers\u2019 experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study","volume":"18","author":"Lawton","journal-title":"BMC Endocr Disord"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251332580","article-title":"Glucose interpretation meaning and action (GIMA): insights to blood glucose user interface interpretation in type 1 diabetes","volume":"11","author":"Kongdee","journal-title":"Digit Health"},{"key":"R17","unstructured":"Chapter 3: diabetes distress. Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/for-professionals\/improving-care\/good-practice\/psychological-care\/emotional-health-professionals-guide\/chapter-3-diabetes-distress [Accessed 17-03-2026]"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0491-3","article-title":"Diabetes and depression","volume":"14","author":"Holt","journal-title":"Curr Diab Rep"},{"key":"R19","unstructured":"Links between diabetes and depression. Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/living-with-diabetes\/emotional-wellbeing\/depression [Accessed 17-03-2026]"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.scib.2024.01.004","article-title":"Large language models for diabetes care: potentials and prospects","volume":"69","author":"Sheng","journal-title":"Sci Bull (Beijing)"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04348-9","article-title":"Large language models in clinical trials: applications, technical advances, and future directions","volume":"23","author":"Lin","journal-title":"BMC Med"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.2196\/57400","article-title":"Large language models for mental health applications: systematic review","volume":"11","author":"Guo","journal-title":"JMIR Ment Health"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.2196\/79091","article-title":"Embracing the future of medical education with large language model-based virtual patients: scoping review","volume":"27","author":"Zeng","journal-title":"J Med Internet Res"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.2196\/84120","article-title":"Knowledge-practice performance gap in clinical large language models: systematic review of 39 benchmarks","volume":"27","author":"Gong","journal-title":"J Med Internet Res"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Guo Z Lai A Ive J et al. Development and evaluation of hopebot: an LLM-based chatbot for structured and interactive PHQ-9 depression screening. arXiv. Preprint posted online on Jan 14, 2026. URL: https:\/\/doi.org\/10.48550\/arXiv.2507.05984 [Accessed 17-03-2026] [doi: 10.21203\/rs.3.rs-6976450\/v1]","DOI":"10.21203\/rs.3.rs-6976450\/v1"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.2196\/70131","article-title":"The effectiveness of a custom AI chatbot for type 2 diabetes mellitus health literacy: development and evaluation study","volume":"27","author":"Kelly","journal-title":"J Med Internet Res"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/78625","article-title":"Evaluating large language models and retrieval-augmented generation enhancement for delivering guideline-adherent nutrition information for cardiovascular disease prevention: cross-sectional study","volume":"27","author":"Parameswaran","journal-title":"J Med Internet Res"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.2196\/72553","article-title":"Generative AI chatbot for diabetes management: formative 2-part qualitative study using DTalksBot involving patients and clinicians","volume":"9","author":"Jeon","journal-title":"JMIR Form Res"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.2196\/60380","article-title":"Application of chatbots to help patients self-manage diabetes: systematic review and meta-analysis","volume":"26","author":"Wu","journal-title":"J Med Internet Res"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1142\/9789819807024_0007","article-title":"LLM-CGM: a benchmark for large language model-enabled querying of continuous glucose monitoring data for conversational diabetes management","volume":"30","author":"Healey","journal-title":"Pac Symp Biocomput"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84003-0","article-title":"A case study on using a large language model to analyze continuous glucose monitoring data","volume":"15","author":"Healey","journal-title":"Sci Rep"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/tmr.2022.0007","article-title":"Diabetes education and support tele-visit needs differ in duration, content, and satisfaction in older versus younger adults","volume":"3","author":"Greenfield","journal-title":"Telemed Rep"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06456-7","article-title":"Applied techniques for putting pre-visit planning in clinical practice to empower patient-centered care in the pandemic era: a systematic review and framework suggestion","volume":"21","author":"Gholamzadeh","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"R34","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1177\/19322968221088601","article-title":"Expert recommendations for using time-in-range and other continuous glucose monitoring metrics to achieve patient-centered glycemic control in people with diabetes","volume":"17","author":"Bellido","journal-title":"J Diabetes Sci Technol"},{"key":"R35","unstructured":"What approvals and decisions do i need? Health Research Authority. URL: https:\/\/www.hra.nhs.uk\/approvals-amendments\/what-approvals-do-i-need [Accessed 02-04-2026]"},{"key":"R36","unstructured":"Zhu J . Diabetes datasets-ShanghaiT1DM and ShanghaiT2DM [dataset]. Figshare; 2022. [doi: 10.6084\/m9.figshare.20444397.v3]"},{"key":"R37","unstructured":"OhioT1DM dataset. University of North Carolina at Charlotte. URL: https:\/\/webpages.charlotte.edu\/rbunescu\/data\/ohiot1dm\/OhioT1DM-dataset.html [Accessed 17-03-2026]"},{"issue":"12","key":"R38","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","journal-title":"Diabetes Care"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.17925\/EE.2022.18.1.20","article-title":"Utilizing the new glucometrics: a practical guide to ambulatory glucose profile interpretation","volume":"18","author":"Doupis","journal-title":"touchREV Endocrinol"},{"issue":"8","key":"R40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/00325481.2022.2110507","article-title":"Stepwise approach to continuous glucose monitoring interpretation for internists and family physicians","volume":"134","author":"Szmuilowicz","journal-title":"Postgrad Med"},{"key":"R41","unstructured":"Quick guide: interpreting CGM data. Diabetes on the net. 2020. URL: https:\/\/diabetesonthenet.com\/journal-diabetes-nursing\/quick-guide-interpreting-cgm-data\/ [Accessed 17-03-2026]"},{"key":"R42","unstructured":"Quality statement 4: continuous glucose monitoring for adults who use insulin and need help monitoring their blood glucose. NICE. 2023. URL: https:\/\/www.nice.org.uk\/guidance\/qs209\/chapter\/Quality-statement-4-Continuous-glucose-monitoring-for-adults-who-use-insulin-and-need-help-monitoring-their-blood-glucose [Accessed 17-03-2026]"},{"key":"R43","unstructured":"AGP report. Accu-Chek. URL: https:\/\/www.accu-chek.co.uk\/training\/cgm\/agp-report [Accessed 17-03-2026]"},{"key":"R44","unstructured":"Managing diabetes. National Institute of Diabetes and Digestive and Kidney Diseases. URL: https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/overview\/managing-diabetes [Accessed 17-03-2026]"},{"key":"R45","unstructured":"Diabetes: what it is, causes, symptoms, treatment and types. Cleveland Clinic. 2023. URL: https:\/\/my.clevelandclinic.org\/health\/diseases\/7104-diabetes [Accessed 17-02-2023]"},{"issue":"8","key":"R46","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","journal-title":"Diabetes Care"},{"key":"R47","unstructured":"Type 2 diabetes in adults: management. NICE. Dec 2, 2015. URL: https:\/\/www.nice.org.uk\/guidance\/ng28 [Accessed 17-03-2026]"},{"issue":"Supple 1","key":"R48","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/dc23-S005","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","journal-title":"Diabetes Care"},{"key":"R49","unstructured":"What is diabetes distress and burnout? Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/living-with-diabetes\/emotional-wellbeing\/diabetes-burnout [Accessed 17-03-2026]"},{"key":"R50","unstructured":"Diabetes and your emotions. Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/living-with-diabetes\/emotional-wellbeing [Accessed 17-03-2026]"},{"key":"R51","unstructured":"10 tips to ease diabetes stress. American Diabetes Association. URL: https:\/\/diabetes.org\/health-wellness\/mental-health\/ease-diabetes-care-stress [Accessed 17-03-2026]"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Zeng G Yang W Ju Z et al. MedDialog: large-scale medical dialogue datasets. Presented at: Proceedings of the 2020 Conference on Empirical Methods in Natural Language Processing (EMNLP); Nov 16-20, 2020:9241-9250; Online. 2020.[Accessed 14-07-2026] [doi: 10.18653\/v1\/2020.emnlp-main.743]","DOI":"10.18653\/v1\/2020.emnlp-main.743"},{"key":"R53","unstructured":"OpenAIEmbeddings integration. LangChain. URL: https:\/\/docs.langchain.com\/oss\/python\/integrations\/embeddings\/openai [Accessed 17-03-2026]"},{"key":"R54","unstructured":"Faiss. Meta AI. URL: https:\/\/ai.meta.com\/tools\/faiss\/ [Accessed 17-03-2026]"},{"key":"R55","unstructured":"Douze M Guzhva A Deng C et al. The Faiss library. arXiv. Preprint posted online on Oct 23, 2025. [doi: 10.48550\/arXiv.2401.08281]"},{"issue":"2","key":"R56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","journal-title":"J Chiropr Med"},{"issue":"2","key":"R57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0013164416678980","article-title":"Using cluster bootstrapping to analyze nested data with a few clusters","volume":"78","author":"Huang","journal-title":"Educ Psychol Meas"},{"issue":"2","key":"R58","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20230137","article-title":"Mixed-effects model: a useful statistical tool for longitudinal and cluster studies","volume":"49","author":"Silveira","journal-title":"J Bras Pneumol"},{"issue":"6","key":"R59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/1440-1681.12086","article-title":"Should we use one-sided or two-sided P values in tests of significance?","volume":"40","author":"Ludbrook","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"R60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","article-title":"Descriptive statistics and normality tests for statistical data","volume":"22","author":"Mishra","journal-title":"Ann Card Anaesth"},{"key":"R61","unstructured":"Wilcoxon signed ranks test. ScienceDirect Topics. URL: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/wilcoxon-signed-ranks-test\/ [Accessed 17-03-2026]"},{"issue":"1","key":"R62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3150\/14-BEJ620","article-title":"Wald tests of singular hypotheses","volume":"22","author":"Drton","journal-title":"Bernoulli"},{"issue":"3","key":"R63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s1364-6613(00)01453-4","article-title":"The turing test: the first 50 years","volume":"4","author":"French","journal-title":"Trends Cogn Sci"},{"key":"R64","unstructured":"The binomial test. Technology Networks. 2024. URL: http:\/\/www.technologynetworks.com\/informatics\/articles\/the-binomial-test-366022 [Accessed 17-03-2026]"},{"issue":"5","key":"R65","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41591-022-01772-9","article-title":"Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"28","author":"Vasey","journal-title":"Nat Med"},{"key":"R66","doi-asserted-by":"crossref","unstructured":"MacFarland TW Yates JM . Kruskal-wallis h-test for oneway analysis of variance (ANOVA) by ranks. In: MacFarland TW Yates JM , editors. Introduction to Nonparametric Statistics for the Biological Sciences Using R. Springer International Publishing; 2016:177-211. [doi: 10.1007\/978-3-319-30634-6_6] ISBN: 978-3-319-30633-9","DOI":"10.1007\/978-3-319-30634-6_6"},{"issue":"6","key":"R67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2025.100948","article-title":"Foundation models and intelligent decision-making: progress, challenges, and perspectives","volume":"6","author":"Huang","journal-title":"Innovation (Camb)"},{"issue":"1","key":"R68","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01604-3","article-title":"Artificial intelligence tools in supporting healthcare professionals for tailored patient care","volume":"8","author":"Kim","journal-title":"NPJ Digit Med"},{"issue":"8","key":"R69","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90208","article-title":"Wearable devices and AI-driven remote monitoring in cardiovascular medicine: a narrative review","volume":"17","author":"Gaoudam","journal-title":"Cureus"},{"issue":"10","key":"R70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000104","article-title":"Challenges and recommendations for wearable devices in digital health: data quality, interoperability, health equity, fairness","volume":"1","author":"Canali","journal-title":"PLoS Digit Health"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0226-6","article-title":"Investigating sources of inaccuracy in wearable optical heart rate sensors","volume":"3","author":"Bent","journal-title":"NPJ Digit Med"},{"issue":"1","key":"R72","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v16.i1.107488","article-title":"Artificial intelligence in mobile health applications: a comprehensive review of its role in diabetes care","volume":"16","author":"Li","journal-title":"World J Methodol"},{"issue":"2","key":"R73","doi-asserted-by":"publisher","DOI":"10.3390\/bios8020050","article-title":"Limits to the evaluation of the accuracy of continuous glucose monitoring systems by clinical trials","volume":"8","author":"Schrangl","journal-title":"Biosensors (Basel)"},{"key":"R74","unstructured":"GLP-1 agonists. Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/about-diabetes\/looking-after-diabetes\/treatments\/tablets-and-medication\/glp-1 [Accessed 17-03-2026]"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103317","article-title":"Inter-observer agreement and reliability assessment for observational studies of clinical work","volume":"100","author":"Walter","journal-title":"J Biomed Inform"},{"key":"R76","unstructured":"How many people in the UK have diabetes?. Diabetes UK. URL: https:\/\/www.diabetes.org.uk\/about-us\/about-the-charity\/our-strategy\/statistics [Accessed 30-05-2026]"},{"key":"R77","unstructured":"Quality statement 3: continuous glucose monitoring for adults on multiple daily insulin injections who cannot self-monitor using capillary blood glucose monitoring in: type 2 diabetes in adults NICE quality standard QS209. National Institute for Health and Care Excellence. 2023. URL: https:\/\/www.nice.org.uk\/guidance\/qs209\/chapter\/Quality-statement-3-Continuous-glucose-monitoring-for-adults-on-multiple-daily-insulin-injections-who-cannot-self-monitor-using-capillary-blood-glucose-monitoring [Accessed 06-06-2026]"},{"key":"R78","unstructured":"National diabetes audit core report 1: care processes and treatment targets 2024-25 underlying data. NHS England Digital. 2026. URL: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-audit\/report-1-cp-and-tt-data-release-2024-25\/nda-report-1-cp-and-tt-data-release-2024-25 [Accessed 06-06-2026]"},{"key":"R79","doi-asserted-by":"crossref","unstructured":"Guo Z Lai A Deng Z Li K . Evaluating the feasibility and acceptability of a GPT-based chatbot for depression screening: a mixed-methods study. In: Xie X Styles I Powathil G Ceccarelli M , editors. Artificial Intelligence in Healthcare AIiH 2024 Lecture Notes in Computer Science. Springer; 2024:258-271. [doi: 10.1007\/978-3-031-67278-1_20]","DOI":"10.1007\/978-3-031-67278-1_20"},{"key":"R80","unstructured":"Guo Z . Diabetes-chatbot. GitHub. 2026. URL: https:\/\/github.com\/candiceguo0528\/Diabetes-chatbot [Accessed 15-07-2026]"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:44:23Z","timestamp":1785761063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e98519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":80,"URL":"https:\/\/doi.org\/10.2196\/98519","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"v28i2e98519"}}